Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MITOCHONDRIAL TRANSFER: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MITOCHONDRIAL TRANSFER |
graph TD
MITOCHONDRIAL_TRANSFER["MITOCHONDRIAL TRANSFER"]
MITOCHONDRIAL_TRANSFER -->|"regulates"| Osteoclastic_Lineage_Commitmen["Osteoclastic Lineage Commitment"]
MITOCHONDRIAL_TRANSFER -->|"regulates"| BONE_RESORPTION["BONE RESORPTION"]
MITOCHONDRIAL_TRANSFER -->|"involved_in"| Skeletal_Homeostasis["Skeletal Homeostasis"]
MITOCHONDRIAL_TRANSFER -->|"regulates"| Bone_Resorption["Bone Resorption"]
MITOCHONDRIAL_TRANSFER -->|"regulates"| Osteoclast_Differentiation["Osteoclast Differentiation"]
MITOCHONDRIAL_TRANSFER -.protects against.-> Osteoarthritis["Osteoarthritis"]
MITOCHONDRIAL_TRANSFER -->|"treats"| Parkinson_s_Disease["Parkinson's Disease"]
MIRO1["MIRO1"] -->|"regulates"| MITOCHONDRIAL_TRANSFER
Mesenchymal_Stromal_Cells["Mesenchymal Stromal Cells"] -->|"involved_in"| MITOCHONDRIAL_TRANSFER
RHOT1["RHOT1"] -->|"regulates"| MITOCHONDRIAL_TRANSFER
GJA1["GJA1"] -->|"mediates"| MITOCHONDRIAL_TRANSFER
GJA1_20k["GJA1-20k"] -->|"involved_in"| MITOCHONDRIAL_TRANSFER
Gja1_20K["Gja1-20K"] -->|"involved_in"| MITOCHONDRIAL_TRANSFER| Target | Relation | Type | Str |
|---|---|---|---|
| stem cell fate | modulates | unknown | 0.95 |
| Osteoclastic Lineage Commitment | regulates | process | 0.92 |
| mitochondrial dysfunction | modulates | mechanism | 0.90 |
| CNS homeostasis | involved_in | unknown | 0.90 |
| BONE RESORPTION | regulates | entity | 0.90 |
| oxidative stress | inhibits | mechanism | 0.90 |
| Skeletal Homeostasis | involved_in | phenotype | 0.88 |
| mitochondrial dysfunction | associated_with | mechanism | 0.85 |
| myeloid cell commitment | regulates | process | 0.85 |
| neuronal apoptosis | protects_against | process | 0.85 |
| Osteoclast Differentiation | regulates | process | 0.85 |
| epithelial cell dysfunction | treats | phenotype | 0.85 |
| Bone Resorption | regulates | process | 0.85 |
| APOPTOSIS | inhibits | process | 0.85 |
| neurodegeneration | inhibits | disease | 0.85 |
| immunomodulation | mediates | unknown | 0.85 |
| mitochondrial dysfunction | contributes_to | mechanism | 0.85 |
| neuronal injury | protects_against | phenotype | 0.85 |
| beta-amyloid plaque deposition | inhibits | unknown | 0.83 |
| neuroinflammation | modulates | mechanism | 0.80 |
| neurodegeneration | involved_in | disease | 0.80 |
| Acute Lung Injury | protects_against | disease | 0.80 |
| neurodegeneration | contributes_to | disease | 0.80 |
| skeletal homeostasis | associated_with | phenotype | 0.80 |
| neuroinflammation | mediates | mechanism | 0.80 |
| Osteoarthritis | protects_against | disease | 0.75 |
| oxidative stress | modulates | mechanism | 0.75 |
| microglial activation | involved_in | mechanism | 0.75 |
| microglial_activation | modulates | mechanism | 0.75 |
| alzheimers | contributes_to | disease | 0.75 |
| glymphatic_clearance | associated_with | mechanism | 0.70 |
| glymphatic clearance | associated_with | mechanism | 0.70 |
| mitochondrial DNA release | associated_with | mechanism | 0.70 |
| Parkinson's Disease | treats | disease | 0.70 |
| Osteoarthritis | therapeutic_target | disease | 0.70 |
| neuronal bioenergetics | protective_against | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| RHOT1 | regulates | gene | 0.95 |
| MIRO1 | mediates | gene | 0.95 |
| RHOT1 | mediates | gene | 0.95 |
| MIRO1 | regulates | gene | 0.95 |
| Mesenchymal Stromal Cells | involved_in | cell_type | 0.95 |
| MIRO1 | involved_in | gene | 0.95 |
| MIRO1 | regulates | entity | 0.95 |
| aerobic exercise | activates | unknown | 0.95 |
| Bone Marrow Mesenchymal Stem Cells | involved_in | cell_type | 0.90 |
| 38941455 | regulate BBB integrity through | paper | 0.90 |
| 38941455 | inhibits | paper | 0.90 |
| GJA1 | mediates | gene | 0.90 |
| 38941455 | maintains | paper | 0.90 |
| mitochondrial quality | associated_with | unknown | 0.86 |
| GCase | involved_in | protein | 0.85 |
| CD38 | associated_with | gene | 0.85 |
| MIRO1 | associated_with | gene | 0.85 |
| tunneling nanotube | mediates | process | 0.85 |
| CD38 | mediates | gene | 0.85 |
| MIRO1 | mediates | gene | 0.85 |
| Gja1-20K | involved_in | protein | 0.85 |
| CD38 | mediates | gene | 0.85 |
| tunneling nanotubes | mediates | process | 0.85 |
| Oxidative Stress | promotes | process | 0.85 |
| GJA1-20k | involved_in | protein | 0.85 |
| connexin 43 | regulates | protein | 0.80 |
| HK2 | involved_in | protein | 0.80 |
| mitochondrial DNA release | associated_with | mechanism | 0.80 |
| Connexin 43 | expressed_in | protein | 0.80 |
| mitochondrial dysfunction | associated_with | mechanism | 0.80 |
| mitochondrial membrane depolarization | associated_with | phenotype | 0.75 |
| GJA1-20k | implicated_in | protein | 0.75 |
| TFEB | modulates | protein | 0.72 |
| tunneling nanotubes | facilitates | process | 0.70 |
| TFAM | involved_in | protein | 0.70 |
| ALOX15 | involved_in | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.559
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Cx43 knockdown effects on mitochondrial transfer | exploratory | osteoarthritis | 0.900 | 0.00 | human bone marrow-derived MSCs | proposed | N/A |
| Confocal imaging of MSC-chondrocyte interactions during mitochondrial | exploratory | osteoarthritis | 0.850 | 0.00 | human bone marrow-derived MSCs | proposed | N/A |
| Auditory nerve responses to combined optogenetic and electrical stimul | validation | sensorineural hearing loss/dea | 0.850 | 0.00 | transgenic mice expressing ChR | proposed | N/A |
| s:** - Test MCU overexpression specifically in layer II neurons in hea | falsification | Neurodegeneration | 0.400 | 0.50 | mouse | proposed | $200,000 |
| Proposed experiment from debate on Mitochondrial transfer between astr | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Proposed experiment from debate on Mitochondrial transfer between astr | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec | validation | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $160,000 |
| ER-Golgi Secretory Pathway Dysfunction in PD - Experiment Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| Exercise-BDNF-Mitophagy Biomarker Study in PD | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Ferroptosis Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| GLP-1 Agonist Neuroprotection Mechanism in PD | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Cytochrome Therapeutics | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| AAV-LRRK2 IND-Enabling Study Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| Gap Junction Dysfunction Validation in Parkinson's Disease | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| AAV-LRRK2 Gene Therapy IND-Enabling Study Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in Parkinson' | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Axonal Transport Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Selective Neuronal Vulnerability to Aging — Mapping Why Specific Neuro | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Synaptic Mitochondrial Resilience Enhancement for Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancer AAVs for targeting spinal motor neurons and descending motor pathways i [PMID:40403722] | Emily Kussick, Nelson Johansen, Naz Task | Cell Reports | 2025 | 19 |
| Organelle-specific autophagy in inflammatory diseases: a potential therapeutic t [PMID:32048886] | Yao RQ, Ren C, Xia ZF, Yao YM | Autophagy | 2021 | 2 |
| Astrocytic Connexin43 in Alzheimer's disease: mechanisms, interaction with P2 re [PMID:41062060] | Xiong W, Su Y, Verkhratsky A, Yi C | Neuropharmacology | 2026 | 1 |
| Miro1: A potential target for treating neurological disorders. [PMID:40403957] | Zeng L, Yang J, Zhang C, Zhu J, Zhong S, | Neuroscience | 2025 | 1 |
| Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates co [PMID:40595567] | Su Y, Li H, Zhang W, Tao S, Wang Q, Zhan | Nat Commun | 2025 | 1 |
| Calcium-Associated Proteins in Neuroregeneration. [PMID:38397420] | Lisek M, Tomczak J, Boczek T, Zylinska L | Biomolecules | 2024 | 1 |
| Should it stay or should it go: gap junction protein GJA1/Cx43 conveys damaged l [PMID:39394955] | Domingues N, Ribeiro-Rodrigues T, Girão | Autophagy | 2024 | 1 |
| Connexin 43 regulates intercellular mitochondrial transfer from human mesenchyma [PMID:39390589] | Irwin RM, Thomas MA, Fahey MJ, Mayán MD, | Stem Cell Res Ther | 2024 | 1 |
| Mitochondria from osteolineage cells regulate myeloid cell-mediated bone resorpt [PMID:38877020] | Ding P, Gao C, Zhou J, Mei J, Li G, Liu | Nat Commun | 2024 | 1 |
| Selective inhibition of cannabinoid CB(1) receptor-evoked signalling by the inte [PMID:37689260] | Maroto IB, Moreno E, Costas-Insua C, Mer | Neuropharmacology | 2023 | 1 |
| lncRNA LOC100911717-targeting GAP43-mediated sympathetic remodeling after myocar [PMID:36684596] | Li P, Wang K, Yin J, Qi L, Hu H, Yang P, | Front Cardiovasc Med | 2022 | 1 |
| Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease. [PMID:33803217] | Chang CH, Lin CH, Lane HY | Int J Mol Sci | 2021 | 1 |
| Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration. [PMID:34199470] | Boal AM, Risner ML, Cooper ML, Wareham L | Cells | 2021 | 1 |
| MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote qualit [PMID:34873283] | König T, Nolte H, Aaltonen MJ, Tatsuta T | Nat Cell Biol | 2021 | 1 |
| Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal ste [PMID:24431222] | Ahmad T, Mukherjee S, Pattnaik B, Kumar | EMBO J | 2014 | 1 |
| Nerve growth cone motility. [PMID:2139335] | Lankford K, Cypher C, Letourneau P | Curr Opin Cell Biol | 1990 | 1 |
| L-Carnitine and Acetyl-L-Carnitine in Drug Poisonings: A Systematic Review of Cl [PMID:41692009] | ["Rezaee H", "Abbasgholizadeh F"] | Journal of applied toxicology | 2026 | 0 |
| Connexin43 Deficiency Leads to Ventricular Arrhythmias by Reprogramming Proline [PMID:41618855] | ["Ying H", "Fan H", "Wang Y", "Jiang R", | Advanced science (Weinheim, Ba | 2026 | 0 |
| Prenatal lipopolysaccharide exposure programs cardiac fibrosis via dysregulating [PMID:41789580] | Wen Y, Yuan Y, Zhang H, Liu Y | Molecular medicine reports | 2026 | 0 |
| Astrocytes Protect Brain Metastatic Breast Cancer Cells From Chemotherapy Throug [PMID:41486609] | Yakati V, Rao SS | Biotechnol Bioeng | 2026 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning MITOCHONDRIAL TRANSFER in their description or question text
Score: 0.591 · neurodegeneration · 2026-04-28
Claims from this analysis should be evaluated across Methodology, challenge, Mitochondrial, transfer, between, neurons;
Score: 0.591 · neurodegeneration · 2026-04-28
Claims from this analysis should be evaluated across Methodology, challenge, Mitochondrial, transfer, between, neurons;
Score: 0.577 · neurodegeneration · 2026-04-28
The consensus is to preserve this as a debated candidate, not a canonical world-model claim. Replication or rerun eviden
Score: 0.577 · neurodegeneration · 2026-04-28
The consensus is to preserve this as a debated candidate, not a canonical world-model claim. Replication or rerun eviden
Score: 0.476 · neurodegeneration · 2026-04-02
Light-activated ion channels in astrocytes trigger calcium influx that stimulates tunneling nanotube formation and mitoc
Score: 0.380 · ALS and Alzheimer's disease · 2026-04-27
Under neurodegenerative stress, astrocytes upregulate CD38, which triggers Erk MAPK signaling to promote tunneling nanot